Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2026 08:30 ET | Source: Aclarion, Inc.

Aclarion Announces $2.5 Million Stock Repurchase Plan

Aclarion Announces $2.5 Million Stock Repurchase Plan
April 21, 2026 08:19 ET | Source: BioAegis Therapeutics

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

NORTH BRUNSWICK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering clinical-stage biotech company developing innovative therapies for inflammatory diseases, announces a...
April 16, 2026 06:47 ET | Source: Aclarion, Inc.

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain
April 14, 2026 08:00 ET | Source: Aclarion, Inc.

Aclarion Receives Pinnacle Award for AI Innovation

Aclarion Receives Pinnacle Award for AI Innovation
April 08, 2026 08:00 ET | Source: Aclarion, Inc.

Aclarion Announces Agreement with Weill Cornell Medicine

Aclarion Announces Agreement with Weill Cornell Medicine
April 07, 2026 08:00 ET | Source: Aclarion, Inc.

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video
March 19, 2026 07:30 ET | Source: Annovis Bio Inc.

Annovis Partners with NeuroRPM to Deploy AI-Powered Digital Biomarker Technology in Parkinson's Disease Study

MALVERN, Pa., March 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
March 17, 2026 06:00 ET | Source: Aclarion, Inc.

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet
March 09, 2026 04:30 ET | Source: numares Health

New paper in Frontiers in Medicine reveals first reliable biomarker test for early kidney transplant rejection detection in living-donor recipients

New paper in Frontiers in Medicine reveals first reliable biomarker test for early kidney transplant rejection detection in living-donor recipients
March 04, 2026 09:30 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global Digital Biomarkers Market to Reach USD 15.60 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, March 04, 2026 (GLOBE NEWSWIRE) -- The Digital Biomarkers Market, valued at USD 4.10 billion in 2024, stood at USD 6.30 billion in 2025 and is projected to advance at a resilient...